(R)-METHYL 4-(PIPERIDIN-2-YL)BENZOATE, 95.0%, 250mg

2,2'-((2-((2-Hydroxyethyl)amino)ethyl)azanediyl)bis(ethan-1-ol), 97%, 250mg

(1R,2S)-2-Amino-1-(N-Boc-amino)cyclopentane, 95.0%, 500mg

1-ethyl-N-methyl-4-piperidinamine, 95.0%, 25g

4,5-Dichloropyridazine-3,6-diol, 95.0%, 10g

Fmoc-D-Ser(tBu)-OH>98.0%(HPLC)(T)5g

3-(ethoxycarbonyl)-1-(2-methyl-4-nitrophenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

2-Cyclohexyl-L-glycine, 97.0%, 500g

N-(2-Iodo-4-(trifluoromethoxy)phenyl)acetamide, 95.0%, 1g

1,2-Bis(2-chloro-5-methoxypyrimidin-4-yl)hydrazine, 95.0%, 1g

7-BROMOISOQUINOLIN-2-IUM-2-OLATE, 95.0%, 5g

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 1L, plastic packaging.

3,5-Difluorophenylisothiocyanate, 97.0%, 5g